Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of SHP640 versus placebo for bacterial conjunctivitis
2016-003361-25Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bacterial conjunctivitis (BC) comparing SHP640 with Placebo (2 arms). Primary endpoint: Clinical resolution status at Day 5. Started Aug 2017; status: completed.
02
Drugs
dexamethasone + povidone-iodine
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on 2016-003361-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003361-25.